Postremission therapy for AML with intermediate risk cytogenetics in first complete remission.

Authors

VYDRA Jan SALEK C SCHWARZ J CETKOVSKÝ Petr ŽÁK Pavel NOVÁK Jan PETEČUKOVÁ Veronika MAYER Jiří RÁČIL Zdeněk

Year of publication 2017
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation

You are running an old browser version. We recommend updating your browser to its latest version.

More info